Innovation

Destruction of a cancer cell by nanoparticles, computer illustration. Conceptual image which illustrates the potential of nanoparticles in the treatment of cancer.

UConn, DIANT Pharma Licenses Continuous Manufacturing Nanoparticle System

UConn researchers have licensed a continuous manufacturing system for nanoparticulate drug delivery systems in support of commercialization.

November 11, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research

Entrepreneurship Research & Discovery